Capital Change Notice

22/06/2026 08:30 NZST, SECISSUE

22 June 2026

Issue of ordinary shares

This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in AFT Pharmaceuticals Limited under the AFT Pharmaceuticals Limited Long Term Incentive Plan.

Section 1: Issuer information

Name of issuer AFT Pharmaceuticals Limited

NZX ticker code AFT

Class of financial product Ordinary shares

ISIN (If unknown, check on NZX website) NZAFTE0001S4

Currency NZD

Section 2: Capital change details

Number issued 8,400

Nominal value (if any) Not applicable

Issue price per security 8,400 of the shares were issued at $3.46 per share

Nature of the payment Not applicable

Amount paid up (if not in full) In full

Percentage of total class of Financial Products issued (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence) 0.01%

For an issue of Convertible Financial Products or Options, the principal terms of Conversion Not applicable

Reason for issue and specific authority for issue 8,400 shares were issued to an employee exercising options under the AFT Pharmaceuticals Limited Long Term Incentive Plan

Total number of Financial Products of the Class after the issue (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue. 104,874,660

Specific authority for the issue, including a reference to the rule pursuant to which the issue is made Directors’ resolution, Listing Rule 4.6

Terms or details of the issue (for example: restrictions, escrow arrangements) The ordinary shares issued rank pari passu with the existing ordinary shares

Date of issue 19 June 2026

Section 3: Authority for this announcement and contact person

Name of person authorised to make this announcement Malcolm Tubby

Contact person for this announcement Malcolm Tubby

Contact phone number +64 9 488 0232

Contact email address malcolm.tubby@aftpharm.com

Date of release through MAP 22 June 2026